4
Changes in Ownership
Ascendis Pharma A/S Filed Acc 0001610717-26-000179
EVP & Chief Financial Officer bought 100 shares at $219.00 ($21,900)
From the SEC's structured data for this filing
Trades in this filing
SMITH SCOTT THOMAS · EVP & Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-02 | Purchase : show line 1 in the form | +100 | $219.00 | $21,900 | 4,367 | D |
| Open-market purchases · 100 sh · avg $219.00 · $21,900 | ||||||
Loading xslF345X06/form4.xml…